Technical Analysis for MAIA - MAIA Biotechnology, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
A | 2.94 | 9.70% | 0.26 |
MAIA closed up 9.7 percent on Friday, April 26, 2024, on 1.18 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Earnings due: May 6
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
New 52 Week Closing High | Bullish | 0.00% | |
Pocket Pivot | Bullish Swing Setup | 0.00% | |
Upper Bollinger Band Walk | Strength | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Above Upper BB | Strength | 0.00% | |
Overbought Stochastic | Strength | 0.00% | |
Upper Bollinger Band Touch | Strength | 0.00% | |
MACD Bullish Signal Line Cross | Bullish | 9.70% | |
Stochastic Reached Overbought | Strength | 9.70% | |
Wide Bands | Range Expansion | 9.70% |
Alert | Time |
---|---|
Up 1 ATR | about 3 hours ago |
Possible Pocket Pivot | about 4 hours ago |
Up 5% | about 5 hours ago |
60 Minute Opening Range Breakout | about 6 hours ago |
Rose Above Previous Day's High | about 6 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/06/2024
MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company was founded in 2018 and is headquartered in Chicago, Illinois.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Life Sciences Immunogen
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Life Sciences Immunogen
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 3.07 |
52 Week Low | 0.82 |
Average Volume | 371,370 |
200-Day Moving Average | 1.75 |
50-Day Moving Average | 1.90 |
20-Day Moving Average | 2.35 |
10-Day Moving Average | 2.32 |
Average True Range | 0.24 |
RSI (14) | 70.76 |
ADX | 34.78 |
+DI | 37.44 |
-DI | 13.41 |
Chandelier Exit (Long, 3 ATRs) | 2.27 |
Chandelier Exit (Short, 3 ATRs) | 2.58 |
Upper Bollinger Bands | 2.85 |
Lower Bollinger Band | 1.85 |
Percent B (%b) | 1.09 |
BandWidth | 42.48 |
MACD Line | 0.19 |
MACD Signal Line | 0.15 |
MACD Histogram | 0.0419 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 3.46 | ||||
Resistance 3 (R3) | 3.43 | 3.21 | 3.38 | ||
Resistance 2 (R2) | 3.21 | 3.08 | 3.23 | 3.35 | |
Resistance 1 (R1) | 3.08 | 3.00 | 3.14 | 3.11 | 3.32 |
Pivot Point | 2.86 | 2.86 | 2.90 | 2.88 | 2.86 |
Support 1 (S1) | 2.73 | 2.73 | 2.80 | 2.77 | 2.56 |
Support 2 (S2) | 2.51 | 2.65 | 2.53 | 2.53 | |
Support 3 (S3) | 2.38 | 2.51 | 2.50 | ||
Support 4 (S4) | 2.42 |